| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Talphera, Inc. (TLPH) has 11 insiders with recent SEC Form 4 filings, including 7 buys and 3 sells. TLPH is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 577.4K | $522.0K | - | |
| Other | 205.0K | $185.3K | - | |
| CFO | 88.3K | $79.8K | - | |
| Other | 73.9K | $66.8K | - | |
| Dir | 38.4K | $34.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2018 | Palmer Pamela P | Chief Medical Officer | Buy | 16,000 | $3.07 | $49,120.00 | +3.5% | |
| Nov 15, 2018 | Edwards Mark G | Director | Buy | 20,700 | $2.82 | $58,376.07 | +12.9% | |
| Nov 13, 2018 | Asadorian Raffi | Chief Financial Officer | Buy | 5,000 | $3.13 | $15,646.00 | +11.9% | |
| Oct 15, 2018 | Hamel Lawrence G | Chief Development Officer | Sell | 5,216 | $5.00 | $26,080.00 | -14.9% | |
| Oct 15, 2018 | Dasu Badri N | Chief Engineering Officer | Sell | 28,351 | $5.00 | $141,755.00 | -34.4% | |
| Sep 24, 2018 | Hamel Lawrence G | Chief Development Officer | Sell | 6,953 | $4.50 | $31,288.50 | -16.6% | |
| Aug 7, 2018 | Angotti Vincent J.55 | Chief Executive Officer | Buy | 10,000 | $2.90 | $28,950.00 | +40.0% | |
| Aug 7, 2018 | Edwards Mark G | Director | Buy | 5,300 | $2.84 | $15,062.60 | +3.4% | |
| Aug 6, 2018 | Palmer Pamela P | Chief Medical Officer | Buy | 37,000 | $2.75 | $101,750.00 | +8.8% | |
| Aug 6, 2018 | Asadorian Raffi | Chief Financial Officer | Buy | 5,000 | $2.75 | $13,725.00 | +18.5% |